Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma

Oncotarget
Hong YangYan Li

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies of the digestive tract in East Asian countries. Multimodal therapies, including adjuvant chemotherapy and neo-adjuvant chemotherapy, have become more often used for patients with advanced ESCC. However, the chemotherapy effect is often limited by patients' drug resistance. This study demonstrated that EIF5A2 (eukaryotic translation initiation factor 5A2) overexpression induced stemness and chemoresistance in ESCC cells. We showed that EIF5A2 overexpression in ESCC cells resulted in increased chemoresistance to 5-fluorouracil (5-FU), docetaxel and taxol. In contrast, shRNAs suppressing eIF5A2 increased tumor sensitivity to these chemotherapeutic drugs. In addition, EIF5A2 overexpression was correlated with a poorer overall survival in patients with ESCC who underwent taxane-based chemotherapy after esophagectomy (P < 0.05). Based on these results, we suggest that EIF5A2 could be a predictive biomarker for selecting appropriate chemo-treatment for ESCC patients and EIF5A2 inhibitors might be considered as combination therapy to enhance chemosensitivity in patients with ESCC.

References

Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Jun 10, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Van TriestG J Peters
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nobutoshi AndoUNKNOWN Japan Clinical Oncology Group
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomoyuki OkumuraYutaka Shimada
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine E Eyler, Jeremy N Rich
Jan 13, 2009·Advanced Drug Delivery Reviews·Robert W RobeySusan E Bates
Jan 30, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dong-Jiang TangXin-Yuan Guan
Sep 11, 2010·International Journal of Cancer. Journal International Du Cancer·Li-Ru HeDan Xie
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Feb 2, 2013·Clinical and Translational Medicine·Lissa Nurrul Abdullah, Edward Kai-Hua Chow
Aug 10, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lulu LiuXin-Yuan Guan
Sep 12, 2013·Molecular Pharmacology·Alexandra E StacyDes R Richardson
Nov 2, 2013·British Journal of Cancer·S KhosraviG Li

❮ Previous
Next ❯

Citations

Jun 27, 2019·World Journal of Gastrointestinal Oncology·Qing-Bin MengWei-Ming Kang
Aug 26, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Elena AndreucciLucia Magnelli
Sep 23, 2018·International Journal of Molecular Sciences·Dimakatso Alice SenthebaneKevin Dzobo
Aug 11, 2020·Computational and Structural Biotechnology Journal·Shicai LiuJinke Wang
Jan 24, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chinmayee Sethy, Chanakya Nath Kundu
Mar 18, 2021·Stem Cell Research & Therapy·Kun WangXingsheng Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.